Fresh blood product manufacture, issue, and use: A chain of diminishing returns?

Trevor J. Cobain*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

9 Citations (Scopus)


The available pool of potential blood donors continues to decrease. There are blood component losses all along the chain of production from the recruitment of the donor, attendance and bleeding of the donor, production process, storage of the inventory in the blood center, storage in the hospital or laboratory, selection, and transfusion of the recipient. There is a requirement and potential to improve product availability by better recruitment strategies, production methods, inventory management, and recipient selection. All of these areas of transfusion medicine have been investigated, and some data and options for improving donor/donation utilization are available in the literature. There are also some developing strategies that have the potential to have a positive influence on the availability of blood components. They include the use of blood components that have often been regarded as expensive. Further studies are required to determine if products such as leukoreduced red cells and platelets, unrefrigerated or fresh whole blood, and some recombinant products can conserve large numbers of other components or reduce hospital costs.

Original languageEnglish
Pages (from-to)279-292
Number of pages14
JournalTransfusion Medicine Reviews
Issue number4
Publication statusPublished - Oct 2004
Externally publishedYes


Dive into the research topics of 'Fresh blood product manufacture, issue, and use: A chain of diminishing returns?'. Together they form a unique fingerprint.

Cite this